Allogene Therapeutics ALLO Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's net margin?
- Allogene Therapeutics (ALLO) reported net margin of -1,170,863.6% in Q4 2024.
- How has Allogene Therapeutics's net margin changed year-over-year?
- Allogene Therapeutics's net margin decreased by 239.9% year-over-year, from -344,489.5% to -1,170,863.6%.
- What is the long-term trend for Allogene Therapeutics's net margin?
- Over 3 years (2021 to 2024), Allogene Therapeutics's net margin has grown at a 1842.9% compound annual growth rate (CAGR), from -159.6% to -1,170,863.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.